State NM
Clinical Trials in New Mexico
New Mexico is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in New Mexico and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 62 actively recruiting studies with New Mexico sites out of 62 registered in total. The busiest research areas in New Mexico are Cardiovascular Diseases, Multiple Myeloma, Endometrial Cancer. Leading sponsors running trials in the state include AstraZeneca, SWOG Cancer Research Network, NRG Oncology. By stage, New Mexico trials break down as Phase 1 (1), Phase 2 (18), Phase 3 (26), Phase 4 (1).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in New Mexico
Frequently Asked Questions — Clinical Trials in New Mexico
How many clinical trials are currently recruiting in New Mexico?
ClinicalMetric currently tracks 62 actively recruiting clinical trials with at least one location in New Mexico. The total number of registered studies—including active but not currently enrolling trials—is 62. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in New Mexico?
New Mexico hosts clinical trials across a broad range of medical conditions, including Cardiovascular Diseases, Multiple Myeloma, Endometrial Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout New Mexico serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in New Mexico?
To join a clinical trial in New Mexico, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in New Mexico maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in New Mexico
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT07436793 Phase 2
Recruiting
Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus B...
Condition
Endometrial Endometrioid Adenocarcinoma
Enrollment
140 pts
Location
United States
Sponsor
New Mexico Cancer Research All
NCT06680830 Phase 2
Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Posi...
Condition
Parkinson Disease
Enrollment
150 pts
Location
United States, Israel, Italy
Sponsor
Neuron23 Inc.
NCT07631598 N/A
Recruiting
Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
Condition
Opioid Use Disorder
Enrollment
512 pts
Location
United States
Sponsor
Montefiore Medical Center
NCT07417111 N/A
Recruiting
Continued Pressure for Alveolar Protection (CPAP Trial)
Condition
Bronchopulmonary Dysplasia (BPD)
Enrollment
860 pts
Location
United States
Sponsor
NICHD Neonatal Research Networ
NCT07333183 Phase 2
Recruiting
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Condition
Pulmonary Hypertension
Enrollment
20 pts
Location
United States
Sponsor
Pulmovant, Inc.
NCT07107945 Phase 3
Recruiting
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and ...
Condition
Chronic Kidney Disease
Enrollment
120 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT07222800 Phase 3
Recruiting
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in...
Condition
Intestinal Neoplasms
Enrollment
800 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
NCT06749457 Phase 1, Phase 2
Recruiting
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase...
Condition
Staphylococcus Aureus
Enrollment
231 pts
Location
United States
Sponsor
AstraZeneca
NCT05408845 Phase 2
Recruiting
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Ch...
Condition
Metastatic Salivary Gland Carcinoma
Enrollment
146 pts
Location
United States
Sponsor
NRG Oncology
NCT04185844 N/A
Recruiting
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
Condition
Diabetes Mellitus
Enrollment
500 pts
Location
United States
Sponsor
University of New Mexico
Page 3 of 3 — 62 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology